who should not take glp-1 drugs nausea: How to handle GLP-1s' most common side effect What does it feel like

for example, exenatide shows higher immunogenicity, while liraglutide and semaglutide have modifications that reduce this risk

Additional file 1: Fig S14)

Encouraged by these results, Novo Nordisk launched the much larger SOUL trial the following year

JLS has been on the Speaker Bureau of Abbott, AstraZeneca, Boehringer Ingelheim/Eli Lilly, Janssen, Merck, Novo Nordisk, Salix and Sanofi, has been a Board Member/Advisory Panel for Ascensia Diabetes, Novo Nordisk, and Sanofi

As GLP-1 therapies such as Semaglutide and Tirzepatide move beyond diabetes management into mainstream obesity treatment, the scale of adoption is unprecedented in India

Hubert P.E